Works matching IS 15233790 AND DT 2024 AND VI 26 AND IP 2
Results: 9
Elderly Rectal Cancer: An Updated Review.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 181, doi. 10.1007/s11912-024-01495-9
- By:
- Publication type:
- Article
Sarcopenia and Neuroendocrine Neoplasms.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 121, doi. 10.1007/s11912-024-01494-w
- By:
- Publication type:
- Article
Germline Mutations and Ancestry in Prostate Cancer.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 175, doi. 10.1007/s11912-024-01493-x
- By:
- Publication type:
- Article
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 164, doi. 10.1007/s11912-023-01492-4
- By:
- Publication type:
- Article
PARP Inhibitors in Breast Cancer: a Short Communication.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 103, doi. 10.1007/s11912-023-01488-0
- By:
- Publication type:
- Article
Prolymphocytic Leukaemia: an Update on Biology and Treatment.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 129, doi. 10.1007/s11912-023-01485-3
- By:
- Publication type:
- Article
Appendiceal Neuroendocrine Neoplasms: an Update for 2023.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 114, doi. 10.1007/s11912-023-01484-4
- By:
- Publication type:
- Article
Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 136, doi. 10.1007/s11912-023-01482-6
- By:
- Publication type:
- Article
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 2, p. 147, doi. 10.1007/s11912-023-01467-5
- By:
- Publication type:
- Article